Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Readers Comments

Back to Item »

Servier Positions Itself to Take Over Full Rights to CNS Disease Drug in Development with Cortex

Firm pays $1 million for option to full rights and will pay another $2 million if it acquires the candidate by October 31.

0 Readers' Comments
  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll